Oppenheimer Raises Amgen Price Target to $450

Amgen's stock price target has been raised to $450 from $400 by Oppenheimer, according to TipRanks. This increase reflects a significant upward revision of the company's valuation. The new target price represents a 12.5% increase over the previous estimate.

The backtested results provided by TipRanks indicate that this strategy has historically performed well, but it is essential to note that past performance does not guarantee future success. Investors should exercise caution and consider all available information before making investment decisions.